Company intelligence / Profile preview

5Y Capital

Shanghai, Shanghai, China5ycap.com ↗

Ownership: Private
Development stage: Other

Overview

5Y Capital is a leading venture capital and private equity firm based in China, formerly known as Morningside Venture Capital. It manages over $5–6 billion USD in assets and focuses on early-stage and growth-stage investments across technology, life sciences, healthcare, therapeutics, pharmaceuticals, biotechnology, clinical trials, and consumer innovation sectors. The firm has backed numerous high-profile startups including Xiaomi and Medbanks Network Technology. Its healthcare/life science investments span therapeutics development platforms such as neoX BIOTECH and healthtech services like Medbanks.

Industry: Investors

Partnerships

TencentJeneration Capital

Beyond the preview

Go deeper on 5Y Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5Y Capital.

Explore the full profile